...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith-Oncology Pipeline

Apparently I can't do math, the $1.50/sh USD on PPs from the company would imply a value of $202M USD not $165M as I stated in my post. Duh!!

Share
New Message
Please login to post a reply